Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Elife ; 62017 05 24.
Artigo em Inglês | MEDLINE | ID: mdl-28537557

RESUMO

Reduced susceptibility to infectious disease can increase the frequency of otherwise deleterious alleles. In populations of African ancestry, two apolipoprotein-L1 (APOL1) variants with a recessive kidney disease risk, named G1 and G2, occur at high frequency. APOL1 is a trypanolytic protein that confers innate resistance to most African trypanosomes, but not Trypanosoma brucei rhodesiense or T.b. gambiense, which cause human African trypanosomiasis. In this case-control study, we test the prevailing hypothesis that these APOL1 variants reduce trypanosomiasis susceptibility, resulting in their positive selection in sub-Saharan Africa. We demonstrate a five-fold dominant protective association for G2 against T.b. rhodesiense infection. Furthermore, we report unpredicted strong opposing associations with T.b. gambiense disease outcome. G2 associates with faster progression of T.b. gambiense trypanosomiasis, while G1 associates with asymptomatic carriage and undetectable parasitemia. These results implicate both forms of human African trypanosomiasis in the selection and persistence of otherwise detrimental APOL1 kidney disease variants.


Assuntos
Alelos , Apolipoproteína L1/genética , Resistência à Doença , Predisposição Genética para Doença , Nefropatias/genética , Tripanossomíase Africana/genética , África Subsaariana , Estudos de Casos e Controles , Genótipo , Humanos , Seleção Genética , Trypanosoma brucei gambiense/imunologia , Trypanosoma brucei rhodesiense/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA